Table 1

Demographic and clinical baseline characteristics of as-treated patients
Characteristics Probiotic n = 5 Synbiotic n = 5 Prebiotic n = 5 Placebo n = 5
Age, Mean ± SD 28 ± 6 26 ± 7 27 ± 6 30 ± 8
Gender
Male 4 5 4 5
Female 1 0 1 0
Race (%)
Hispanic 5 (100) 5 (100) 5 (100) 5 (100)
Body mass index (kg/m2) Mean ± SD 24 ± 2 23 ± 6 25 ± 6 24 ± 6
Clinical stage (%) Stage A: 15 Stage A: 14 Stage A: 10 Stage A: 18
Stage B: 85 Stage B: 86 Stage B: 90 Stage B: 82
HIV RNA level (copies/mL), median 68100 56881 40800 54460
CD4 cell count (cells/mm3), mean 754 620 533 542
Cholesterol (mg/dL) Mean ± SD 137 ± 16 161 ± 32 179 ± 53 148 ± 13
Triglycerides (mg/dL) Mean ± SD 88 ± 27 105 ± 27 149 ± 65 118 ± 79
IBS-QoL scale score 34 36 35 34

González-Hernández et al.

González-Hernández et al. Nutrition Journal 2012 11:90   doi:10.1186/1475-2891-11-90

Open Data